Evidence map›Paper›PMID 42117685›Full record

ArticlemBio2026

SspE-mediated immune defense: GTP hydrolysis as an allosteric switch coupling phosphorothioate recognition to DNA cleavage.

Yufeng Zhou, Kuo Zhang, Yu He, Haiyan Gao, Yuhang Zhong, Xiaoguang Wang, Meiying Wang, Lianrong Wang, Shi Chen

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yufeng Zhou *Department of Gastroenterology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Disease, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.ORCID 0009-0003-5324-5191
Kuo Zhang *Department of Respiratory Diseases, Institute of Pediatrics, Shenzhen University Medical School, Shenzhen Children's Hospital, Shenzhen, China.
Yu HeDepartment of Respiratory Diseases, Institute of Pediatrics, Shenzhen University Medical School, Shenzhen Children's Hospital, Shenzhen, China.
Haiyan GaoDepartment of Gastroenterology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Disease, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Yuhang ZhongDepartment of Gastroenterology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Disease, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.
Xiaoguang WangDepartment of Surgery, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.
Meiying WangDepartment of Rheumatology and Immunology, Shenzhen Key Laboratory of Microbiology in Genomic Modification & Editing and Application, Shenzhen Institute of Translational Medicine, Shenzhen University Medical School, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.ORCID 0000-0003-3563-9974
Lianrong WangDepartment of Respiratory Diseases, Institute of Pediatrics, Shenzhen University Medical School, Shenzhen Children's Hospital, Shenzhen, China.ORCID 0000-0003-1669-6340
Shi ChenDepartment of Gastroenterology, Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Disease, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, China.ORCID 0000-0002-8965-1015

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA phosphorothioate (PT) modification is an epigenetic mark that enables bacteria to discriminate self from non-self DNA, directing restriction effectors to cleave unmodified foreign DNA. In the PT-dependent Ssp system, SspE acts as the restriction effector that recognizes PT marks to block phage propagation. While the mechanism of the Streptomyces homolog (StSspE) is known, the basis for the exceptional potency of

Indexed as

Bacterial ProteinsDNA CleavageEscherichia coliEscherichia coli ProteinsGuanosine TriphosphatePhosphatesAllosteric RegulationCryoelectron MicroscopyHydrolysisPhosphorothioate OligonucleotidesBacterial ProteinsEscherichia coli ProteinsGuanosine TriphosphatePhosphatesPhosphorothioate Oligonucleotidesallosteric regulationanti-phage defenseDNA phosphorothioation

Identifiers

PMID42117685
PMCPMC13251355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.